Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece

Overview of attention for article published in BMC Health Services Research, September 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 76 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 325 followers.

#Costeffectiveness of #liraglutide vs #sitagliptin or #exenatide in uncontrolled Greek #diabetics: #ICER E7-15k/QALY http://t.co/mNT3xNkMTM

Reply Repost Favourite

Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide #T2DM http://t.co/ulfIOFMd8C

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.